Comparative Hepatology

Table 2 Serum levels of sFas, sTNFR-II, sIL-2R and IL-8 in the different study groups.

From: Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4

Cytokines (pg/ml)	Control	PNALT	CLD	HCC	p-value
sFas	316 ± 62.5^b	605.82 ± 304^ab	814.94 ± 362^a	762.18 ± 437^a	< 0.001
sTNF-RII	375.26 ± 58.4^ab	268.58 ± 129^b	315.27 ± 133.5^b	480.16 ± 154.4^a	< 0.001
sIL-2Rα	639.84 ± 78.7^b	710.10 ± 422^b	845.38 ± 385.2^ab	1372.58 ± 779.6^a	0.001
IL-8	345.84 ± 75.6^a	350.7 ± 53.6^a	352.33 ± 98.3^a	228.61 ± 51.1^b	< 0.001

Values are expressed as mean ± SD. Groups with similar letters are not statistically different. A p-value < 0.05 was considered significant; PNALT: chronic hepatitis C with persistent normal alanine aminotrasferase; CLD: chronic liver disease; HCC: hepatocellular carcinoma.

Back to article page